Literature DB >> 22815114

Why do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across 10 European countries.

James Gaughan1, Conrad Kobel, Caroline Linhart, Anne Mason, Andrew Street, Padraic Ward.   

Abstract

We analyse variations in cost or length of stay (LoS) for 66,587 patients from 10 European countries receiving a coronary artery bypass graft (CABG) procedure. In five of these countries, variations in cost are analysed using log-linear models. In the other five countries, negative binomial regression models are used to explore variations in LoS. We compare how well each country's diagnosis-related group (DRG) system and a set of patient-level characteristics explain these variations. The most important explanatory factors are the total number of diagnoses and procedures, although no clear effects are evident for our CABG-specific diagnostic and procedural variables. Wound infections significantly increase LoS and costs in most countries. There is no evidence that countries using larger numbers of DRGs to group CABG patients are better at explaining variations in cost or LoS. However, refinements to the construction of DRGs to group CABG patients might recognise first and subsequent CABGs or other specific surgical procedures, such as multiple valve repair.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22815114     DOI: 10.1002/hec.2842

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  9 in total

1.  Peripheral nerve blocks in shoulder arthroplasty: how do they influence complications and length of stay?

Authors:  Ottokar Stundner; Rehana Rasul; Ya-Lin Chiu; Xuming Sun; Madhu Mazumdar; Chad M Brummett; Reinhold Ortmaier; Stavros G Memtsoudis
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

Review 2.  Patient-level costs of major cardiovascular conditions: a review of the international literature.

Authors:  Gina Nicholson; Shravanthi R Gandra; Ronald J Halbert; Akshara Richhariya; Robert J Nordyke
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-21

3.  Pre-operative depression predicted longer hospital length of stay among patients undergoing coronary artery bypass graft surgery.

Authors:  Mohannad Eid AbuRuz
Journal:  Risk Manag Healthc Policy       Date:  2019-05-13

4.  Evaluation of Depression and Anxiety in Coronary Artery Bypass Surgery Patients: A Prospective Clinical Study.

Authors:  Melike Elif Teker Açıkel
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27

5.  Predicting Hospital Length of Stay at Admission Using Global and Country-Specific Competing Risk Analysis of Structural, Patient, and Nutrition-Related Data from nutritionDay 2007-2015.

Authors:  Noemi Kiss; Michael Hiesmayr; Isabella Sulz; Peter Bauer; Georg Heinze; Mohamed Mouhieddine; Christian Schuh; Silvia Tarantino; Judit Simon
Journal:  Nutrients       Date:  2021-11-16       Impact factor: 5.717

6.  The combined association of depression and socioeconomic status with length of post-operative hospital stay following coronary artery bypass graft surgery: data from a prospective cohort study.

Authors:  Lydia Poole; Elizabeth Leigh; Tara Kidd; Amy Ronaldson; Marjan Jahangiri; Andrew Steptoe
Journal:  J Psychosom Res       Date:  2013-11-06       Impact factor: 3.006

7.  Is quality costly? Patient and hospital cost drivers in vascular surgery.

Authors:  Marie Kruse; Jan Christensen
Journal:  Health Econ Rev       Date:  2013-10-21

8.  Coronary artery bypass grafts and diagnosis related groups: patient classification and hospital reimbursement in 10 European countries.

Authors:  James Gaughan; Conrad Kobel
Journal:  Health Econ Rev       Date:  2014-04-10

9.  How Well Do All Patient Refined-Diagnosis-Related Groups Explain Costs of Pediatric Cancer Chemotherapy Admissions in the United States?

Authors:  Heidi Russell; Andrew Street; Vivian Ho
Journal:  J Oncol Pract       Date:  2016-04-26       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.